Medios, a provider of specialty pharma solutions, agreed to acquire Ceban Pharmaceuticals, a pharmaceutical compounding platform, for €259m. “We are excited to become part of Medios. Its nationwide network of pharmacies provides us access to the interesting and sizable German market, in which Medios has built an impressive leading position. Moreover, the strategy of Medios fits seamlessly with our international strategic ambitions. Medios’ strong and long relationship with major pharmaceutical companies will allow us to benefit from a solid supply chain, excellent product availability, and a very strong purchase power. We look forward to building the leading European Specialty Pharma platform together," Jeroen van der Hamsvoort, Ceban Pharmaceuticals CEO.